MediSim VR builds virtual reality simulation and AI-assisted competency assessment for medical, nursing and allied health education. It supplies institutions with managed VR labs, training stations, repeatable simulation content and instructor analytics. STRIV teaches and assesses clinical procedures through guided and evaluation modes. DIVE lets medical students practice patient histories, examinations and diagnostic decisions with simulated patients. StudySim provides interactive anatomy and physiology learning. The company also markets hospital VR experiences for patient education, acute pain, anxiety and stress, and invites clinical trials; these are issuer-described applications without a verified product-specific regulatory approval or guaranteed clinical outcome. The legal business is MediSim VR Private Limited, incubated in the IIT Madras ecosystem. Its technology combines immersive simulations with haptic interaction and learning performance assessment; claimed AI analytics support feedback, personalized learning and cohort analysis.
Hariharasuthan S Published company affiliation (formal title and current tenure unverified) Kalidhasan A Published company affiliation (formal title and current tenure unverified) Mohammed Irfan Published company affiliation (formal title and current tenure unverified) Nimeshika J. Strategic partnerships (self-published function; formal title unverified) Riddhi Baid Published company affiliation (formal title and current tenure unverified) Saurin Modh Head of Sales, Central and Western India (published appointment; current membership unverified) Vijay Adhitya S.K. Channel partnership contact (published affiliation; current employment unverified)
SHOW MORE
team@apexlogos.ai · 11 hours ago
Financing precision: own The Chennai Angels source proves INR35000000 Pre-SeriesA led by IPV with TCA and Jana Balasubramaniam; precise original announcement day unresolved. Own2022 Kauvery investment announcement plus named parent executive testimony ties the event to Healthcare Capital; amount, conventional stage, exact day, individual ticket and vehicle allocation are unpublished. Primary IIT Madras NIRF2025 table reports raw212300000 with Wall Street Ventures LLC/New York and Vizor Capital Pty Ltd/Sydney in2023–24, and separately raw97764800 with Vizor Capital in2023–24, both Pre-SeriesA. The table does not label currency; these may overlap or represent annual totals/components and are not added, converted or booked as exact separate rounds. Earlier NIRF versions contain a lower IPV figure conflicting with own TCA and latest gov2025 row; own backer35m controls. Own8XVentures portfolio explicitly labels MediSim VR holding SPV; exact date/amount/event unpublished. Full missing backers and Jana identity are queued before additional investor participation, without generic bare stubs or invented fund allocation. SHOW MORE
team@apexlogos.ai · 11 hours ago
Public people coverage: seven named current website founders/advisers and fifteen additional directly published self-profile/issuer/bylined or institutional affiliations are included. Supplementary roles explicitly qualify unknown formal titles/current tenure, and are not asserted to be a complete live payroll. Vijay Adhitya’s issuer channel-contact post and separately indexed Mad Street Den headline leave current employment unresolved. Malav S Trivedi’s external a2 Milk versus NSU biographies are source-published/current-unverified. Issuer tags, congratulations, workshop guests and automatic LinkedIn cards alone are not employment proof; unresolved tagged identities remain in companion queue. No invented start/end dates or namesake merges. SHOW MORE
team@apexlogos.ai · 11 hours ago
Legal/date/clinical precision: IIT Madras Research Park identifies MediSim VR Private Limited, incorporated2018; own LinkedIn lists founded2017 while issuer2022 press release says founded2018. A single founding date is therefore omitted pending reconciliation. Israeli Medisim (medisim.co.il) is a separate medical device business. Educational VR and AI analytics are issuer-described functionality. Hospital pain/anxiety/stress and patient education VR are marketed with clinical-trial invitations; cited general VR studies do not establish this product’s regulatory clearance, guaranteed clinical efficacy or validated therapeutic outcome. J&J Innovation/JLABS residency and IIT Madras incubation are support affiliations, not automatically cash investors. SHOW MORE
